Upper Extremity Injury Clinical Trial
Official title:
Feasibility and Efficacy of the Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients: a Randomized Pilot Study
Stroke is one of the leading causes of death and disability and has been described as a worldwide epidemic (1). Stroke survivors are affected by impairments and limitations of cognitive, language, perceptual, sensory, and motor functions. After a stroke, patients can improve spontaneously within the first 3 months (2) and then more slowly in the following year. The first day, decreased oedema and partial reperfusion of the ischemic penumbra may possibly explain these phenomena, but the improvement of neurological deficit in the following weeks suggests plasticity phenomena and brain cortical reorganization (3). While most recovery is thought to be made in the first few weeks after stroke, patients may make improvements on functional tasks many months after having a stroke (4). Restoring arm and hand skill after a stroke remains challenging, even though stroke rehabilitation programs have proven partial efficacy Repetitive task training has been shown to be effective in some aspects of rehabilitation, such as improving walking distance and speed and improving upper limb function (5). In this project, the investigators will use "Gloreha ARIA" (7) a new sensor-based therapy device designed for motor recovery of impaired upper limb Gloreha Aria offers specific programs that help patients to move arm, wrist and fingers. Therapists can customize therapy by focusing on a specific motor task.
The hypothesis was that rehabilitation with this device could be not inferior in comparison with hands-on physiotherapy, in the reeducation of upper arm in the patient affected by stroke from cerebral ischemia or hemorrhage that had occurred ≤ 30 days before. The principle purpose of this study will be to evaluate: 1. The feasibility of this new device 2. Efficacy in improving arm function abilities in the rehabilitation of patients with stroke in the sub-acute phase. Post-stroke patients admitted for inpatient rehabilitation to the Neurological Rehabilitation will be screened for enrolment and randomized in a controlled trial. All the patients will be informed about the aim and experimental procedures before enrolment, thus written informed consent will be obtained from all of them. Patients included in the study will be randomly assigned to intervention or control group according to simple randomization technique (computerized random numbers). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05691673 -
Upper Extremity Force-velocity Profile in Swimmers
|
||
Completed |
NCT03677778 -
Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade
|
N/A | |
Recruiting |
NCT04501510 -
Ultrasonography in Fracture Management
|
||
Not yet recruiting |
NCT06356415 -
Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone
|
N/A | |
Completed |
NCT05359731 -
Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade
|
Phase 4 | |
Completed |
NCT03807505 -
Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery
|
N/A | |
Recruiting |
NCT03595514 -
Single Versus Double Injection Costoclavicular Block
|
N/A | |
Withdrawn |
NCT01605929 -
Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block
|
N/A | |
Recruiting |
NCT04994405 -
Lower Tourniquet Pressure Study
|
N/A | |
Completed |
NCT04019990 -
Throwers Ten Exercises On Upper Extremity Function and Explosive Power in Wheelchair Basketball and Basketball Players
|
N/A | |
Recruiting |
NCT03702387 -
Evaluation of Second Esmarch Application on Intravenous Regional Anesthesia Effectiveness
|
N/A | |
Recruiting |
NCT05261425 -
Suture Closure Trial
|
N/A | |
Completed |
NCT05476198 -
Brachial Plexus Block vs. General Anesthesia for Anesthesia Anxiety Before Orthopedic Upper Extremity Surgery
|
N/A | |
Completed |
NCT05422989 -
Public Health Risks and Characteristics of Upper Extremity Trauma During COVID-19
|
||
Recruiting |
NCT06016647 -
Multi-axis Assessment of Injured Workers
|
||
Completed |
NCT04875039 -
Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks
|
Phase 4 | |
Completed |
NCT03610893 -
Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks
|
N/A | |
Enrolling by invitation |
NCT05328934 -
SoftHand Comparison Study
|
N/A |